Proton and Proton-Photon Hybrid Partial Stereotactic Ablative Boost Radiotherapy (P-SABR) for Unresectable Large Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Proton and Proton-Photon Hybrid Partial Stereotactic Ablative Boost Radiotherapy (P-SABR) for Unresectable Large Tumors	Bulky Tumor; Solid Tumor; Unresectable Malignant Neoplasm	Not yet recruiting	Not stated	2026-09-14		NCT07818798

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking University First Hospital	225

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials